Dear Colleague,
Welcome to the latest update from HospitalPharma.com
  Tevadaptor - for safe handling of hazardous drugs

TEVA Hospitals announces the launch of Tevadaptor (12th May 2006), a system for safe compounding and administration of hazardous IV drugs. The Tevadaptor system combines the safety of a closed, needle-free system with superb ease of use.

 

Cytotoxics, but also other drugs.

The potential risks of exposure to cytotoxic drugs appear to be well recognized, and a number of other drugs are also identified as risky. In a recent Alert issued by the US NIOSH[1], antivirals and hormones were also identified as potentially hazardous.

 

But what about antibiotics? The number of IV antibiotic doses administered every day is probably a factor 5 to 10 larger than that of cytotoxics, and the amount of drug per dose is often in the order of grams rather than milligrams. The increased awareness of the potential risks (including building resistance) of exposure to antibiotics warrants reviewing the procedures for handling these drugs. We need to protect the people who care for us and our families daily the best we can.



[1] National Institute for Occupational Safety and Health

Read More
Featured Jobs
PharmacistsAll IrelandExcellent Benifits and Relocation package
Laboratory ScientistsHertfordshireOn Application
Managing Pharmacist Bonus, Relocationm, Etc Etc
Managing Pharmacist-Kerry
Pharmacovigilance Associates And Scientists Comprehensive benefits package
Pw 2230 Medical Information Contract / Mio / Contract / Maidenhead / Berkshire The successful candidate will enjoy a competitive
Regional Clinical PharmacistBUPA, Car, Bonus, PHI, Pension, Life Assurance
More Jobs
MHRA Drug Alerts
11 Apr 2006 | Class 4 medicines defect information: Glaxo SmithKline Plc, Pentosam Injection, PL 00003/5105R - EL(06)A15
Due to a manufacturing issue, particulates may be present in vials of this product and alternative stock is unlikely to be available for many months.
22 Mar 2006 | Class 3 medicines recall (action within 5 days): Boehringer Ingelheim Ltd, Oramorph Oral Solution 100ml bottles 10mg/5ml, EL(06)A/14
Boehringer Ingelheim Ltd is recalling a batch of Oramorph Oral Solution due to the absence of labels on a number of 100ml bottles.
21 Mar 2006 | Class 1 medicines recall (action now - including out of hours): GE Healthcare Ltd, Myoview 10ml vials, EL(06)A/13
GE Healthcare Ltd is recalling a batch of Myoview 10ml vials as a precautionary measure following the discovery that gas filters used in the aseptic manufacturing process are not sterile.
16 Mar 2006 | Class 3 medicines recall (action within 5 days): Martindale Pharmaceuticals, Chloramphenicol Eye Ointment BP 1%w/w and Hydrocortisone Eye Ointment BPC 1% w/w, EL(06)A12
Martindale Pharmaceuticals is recalling a batch of Chloramphenicol Eye Ointment which contains a small number of tubes labelled as Hydrocortisone Eye Ointment BPC 1% w/w bearing the Chloramphenicol batch and expiry details.
15 Mar 2006 | Class 2 medicines recall (action within 48 hours): B.M Browne U.K. Ltd, Water for Injection Ph. Eur. 10 ml ampoules, EL(06)A/11
B.M Browne U.K.Ltd., on behalf of Noridem Enterprises, is recalling one batch of Water for Injection Ph. Eur. 10ml ampoules as a precautionary measure due to the barcode label on the reverse of some ampoules being a barcode label for Sodium Chloride 0.9%.
More PharmiWeb Features
HospitalPharma Today Stories
11/05Don't actually pour it into your ears!
08/05A quicker Tamiflu
05/05A Rat in the kitchen is bad for your teeth
04/05Can we borrow your drugs please?
More HospitalPharma Today Stories
HospitalPharma Features
The value of Marketing and PR in clinical research
- Dr Faiz Kermani (10/05/2006)
World Pharmaceutical (China) Summit 2006
- IBG Company Limited (10/05/2006)
RNA interference (RNAi) is coming of age as a therapeutic modality
- La Merie Business Intelligence (09/05/2006)
Pharma's growing concern over parallel trade
- Datamonitor (05/05/2006)
More HospitalPharma Features
Featured Events
15 Oct...The Pharmacy Show the NEC Birmingham
More HospitalPharma Events
Press Releases
New Data Show Improved Outcomes With Humira (adalimumab) In Rheumatoid And Psoriatic Arthritis
- ABBOTT (08/05/2006)
Large Irish Pharmacy Network Look To The Uk
- Pharmaseek Recruitment (08/05/2006)
Medical Science Liaison Webinars Address Msl Core Competencies
- Medical Science Liaison Institute (05/05/2006)
Integrated Services From Dsm Pharmaceutical Products
- Integrated Services from DSM Pharmaceutical Produc (05/05/2006)
More Press Releases
Much more than just news and jobs
As well as owning and managing www.pharmiweb.com, PharmiWeb Solutions delivers business benefits through our 3 key areas of expertise:
[ Portals ] [ E-business ] [ Mobility ]
PharmiWeb Solutions

Best Regards

Mike Wood ...and the team at HospitalPharma

To ensure that your PharmiWeb e-mails get to your inbox, please add mike@pharmiweb.com to your e-mail Address Book or Safe List.

For editorial enquiries regarding this newsletter or the website, please contact editor@pharmiWeb.com , call: +44 (0) 1344 667448 or contact mike@pharmiweb.com.

Please note: we are not responsible for content that is external to our site, submitted to us by our contributors or outside our direct control.